Article
Long-term follow-up in osteogenesis imperfecta type VI.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA - 1 Oct 2017
Trejo P, Palomo T, Montpetit K, Fassier F, Sato A, Glorieux F H, Rauch F
Abstract excerpt
This retrospective study on long-term outcomes in osteogenesis imperfecta type VI found that patients who received intravenous bisphosphonate treatment had an increase in lumbar spine areal bone mineral density, a higher final height z-score, and some reshaping of vertebral bodies. INTRODUCTION: Osteogenesis imperfecta (OI) type VI is an ultra-rare bone fragility disorder caused by recessive mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.